Reshma Quadros

No ORCID on file · 2 papers in corpus · active 2026

Study types

  • other 1
  • rct 1

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
other 2026
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority Study
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.70256

OBJECTIVE: To compare the efficacy, safety and tolerability of elagolix with dienogest in women with moderate-to-severe endometriosis-associated pain. DESIGN: A multicentre, double-blind, double-dummy, randomised, parallel-group, active-co…

rct 2026
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions
Clinical pharmacology in drug development ·doi:10.1002/cpdd.70053

Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical d…